UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB

dc.contributor.author	Inanc, N; Abacar, K; Ozturk, MA; Tufan, A; Karadeniz, H; Sari, I; Can, G; Erez, Y; Pehlivan, Y; Dalkilic, E; Ocak, T; Cefle, A; Yazici, A; Senel, A; Akar, S; Ediboglu, ED; Koca, SS; Sagir, RP; Yilmaz, S; Gulcemal, S; Gunduz, OS; Basibuyuk, CS; Alkan, S; Cesur, TY; Onen, F
dc.date.accessioned	2023-03-02T06:38:59Z
dc.date.available	2023-03-02T06:38:59Z
dc.date.issued	JUN
dc.date.issued	2022
dc.identifier.uri	http://hdl.handle.net/20.500.12481/14311
dc.title	UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB
dc.title.alternative	ANNALS OF THE RHEUMATIC DISEASES
dc.identifier.DOI-ID	10.1136/annrheumdis-2022-eular.5102
dc.identifier.volume	81
dc.identifier.startpage	1338
dc.identifier.endpage	1338
dc.identifier.issn/e-issn	0003-4967
dc.identifier.issn/e-issn	1468-2060

Files in this item

Files	Size	Format	View
There are no files associated with this item.